SCHEMBL9212652

SCHEMBL9212652

CCCCCCCNC(=O)c1oc(-c2ccc(Cl)cc2)c2cc(C)cc(C)c12

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.43
CNR2 P34972 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 2/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TP53 P04637 1/20 0.40
MDM2 Q00987 1/20 0.40
ALOX15 P16050 1/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9213695 0.85 L3MBTL1 (0.46) CNR1CNR2L3MBTL1ALDH1A1HPGD
SCHEMBL9219551 0.85 L3MBTL1 (0.46) CNR1CNR2L3MBTL1ALDH1A1HPGD
SCHEMBL9218058 0.84 L3MBTL1 (0.44) CNR1CNR2L3MBTL1ALDH1A1HPGD
SCHEMBL9212636 0.82 TP53 (0.49) CNR1CNR2L3MBTL1ALDH1A1TP53
SCHEMBL9219857 0.81 NAAA (0.48) CNR1CNR2ALDH1A1HPGDKDM4E
SCHEMBL9212406 0.78 L3MBTL1 (0.53) L3MBTL1ALDH1A1HPGDTP53LMNA
SCHEMBL9209891 0.78 HPGD (0.45) CNR1CNR2ALDH1A1HPGDKDM4E
SCHEMBL9219621 0.78 CSNK2A2 (0.46) ALDH1A1HPGDKDM4ETP53LMNA
SCHEMBL9219544 0.76 TP53 (0.50) CNR1CNR2L3MBTL1TP53MDM2
SCHEMBL9430499 0.76 TP53 (0.50) CNR1CNR2L3MBTL1TP53MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0512570-B1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1995-10-11 EP disclosed
EP-0512570-A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-11-11 EP disclosed